EYEG Eyegate Pharmaceuticals Inc

Eyegate Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. The Company is engaged in developing and commercializing products for treating diseases and disorders of the eye.

As of 06/18/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/13/2015
Outstanding shares:  7,097,912
Average volume:  27,104
Market cap:   $32,011,583
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    30233M503
ISIN:        US30233M5031
Sedol:      BKS3LD0
Valuation   (See tab for details)
PE ratio:   -13.31
PB ratio:   2.54
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy